<DOC>
	<DOCNO>NCT00447941</DOCNO>
	<brief_summary>Study assess pharmacokinetics , pharmacodynamics , safety , tolerability oral dose SCA-136 healthy male Japanese subject</brief_summary>
	<brief_title>Safety , PK PD Study Healthy Male Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Inclusion Criteria Men age 20 45 year time obtain informed consent . Body mass index ( BMI ) range 18.5 25.0 kg/m2 body weight â‰¥ 50 kg . Healthy determine investigator basis medical history , physical examination , clinical laboratory test result , vital sign , 12lead electrocardiogram ( ECG ) . Exclusion Criteria Presence history disorder may prevent successful completion study . Any significant cardiovascular , hepatic , renal , respiratory , gastrointestinal , endocrine , immunologic , dermatologic , hematologic , neurologic , psychiatric disease . Any surgical medical condition may interfere absorption , distribution , metabolism , excretion ( ADME ) test article ( eg , resection liver , kidney , gastrointestinal tract ) .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>